Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Annual Summit

  • Date: Thursday, July 24, 2025
  • Time: 8:45am EDT to 4:45pm EDT

We are delighted to announce that the Annual Summit for the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Program will be held on July 24, 2025.

This summit will be a hybrid meeting. For NCI/NIH staff, please indicate if you are planning to attend it in person (Shady Grove) or virtually in the registration link.

About CAP-IT Program

Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) was launched by National Cancer Institute to undertake collaborative research with the overarching goal of discovering molecularly or immunologically targeted agents for cancer prevention and interception.

CAP-IT seeks to establish a new discovery research paradigm in cancer prevention that leverages the potential oncotarget leads identified from precancer biology research and related databases and exploits their oncogenic characteristics and vulnerabilities to discover innovative cancer prevention-interception agents especially focusing on higher-risk populations.

The ultimate goals of CAP-IT are to advance newly discovered efficacious cancer preventive or interceptive agents to the existing NCI, Division of Cancer Prevention preclinical and clinical development pipelines, PREVENT Program, for further development towards IND and Cancer Prevention Clinical Trials Network (CP-CTNet) for early phase clinical trials for fast-tracking agent discovery and development for cancer prevention and interception from bench to bedside.

For more information on CAP-IT please visit: NCICAP-IT.org or email: CAP-IT@nih.gov

We are excited to share CAP-IT Program Centers’ updates with you and look forward to your participation.